BioAtla, Inc.
BCAB
$1.23
-$0.03-2.38%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 47.15% | 18.20% | 14.57% | 20.91% | 43.08% |
| Total Depreciation and Amortization | -74.14% | -64.29% | -59.68% | -45.35% | -31.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.20% | -22.75% | -25.24% | -38.60% | -56.96% |
| Change in Net Operating Assets | 182.09% | 548.09% | 144.33% | 107.68% | 111.29% |
| Cash from Operations | 55.12% | 35.22% | 32.99% | 32.92% | 51.23% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -94.99% | -94.63% | -98.95% | 2,281.68% | 2,199.75% |
| Repurchase of Common Stock | 31.25% | 40.32% | -13.04% | 47.37% | 58.97% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -67.12% | -124.04% | -- | -- | -- |
| Cash from Financing | -23.11% | -25.72% | -34.01% | 2,700.00% | 2,957.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.65% | 37.01% | 32.83% | 43.14% | 59.40% |